|
drug susceptibility
|
IDO_0000469 |
|
|
complex infection
|
IDO_0000471 |
|
|
immune population
|
IDO_0000592 |
|
|
transmission period
|
IDO_0000593 |
|
|
_obsolete_vertical transmission
|
IDO_0000230 |
|
|
_obsolete_modulation of inflammatory response
|
IDO_0000110 |
|
|
_obsolete_horizontal transmission
|
IDO_0000231 |
|
|
intracellular infection
|
IDO_0000473 |
|
|
direct host exposure to infectious agent
|
IDO_0000594 |
|
|
potential host of infectious agent
|
IDO_0000595 |
|
|
_obsolete_antigenic variation
|
IDO_0000111 |
|
|
systemic infection
|
IDO_0000474 |
|
|
_obsolete_pathogen life cycle stage
|
IDO_0000232 |
|
|
_obsolete_infectious disease progression stage
|
IDO_0000233 |
|
|
_obsolete_resist phagocytosis in subepithelial space
|
IDO_0000112 |
|
|
_obsolete_object
|
IDO_0000003 |
|
|
infectious disease lifetime prevalence
|
IDO_0000487 |
|
|
_obsolete_virulence
|
IDO_0000004 |
|
|
infectious agent seroprevalence
|
IDO_0000488 |
|
|
_obsolete_swollen
|
IDO_0000005 |
|
